摘要
目的:观察生脉注射液治疗分水岭脑梗死(CWI)的临床疗效。方法:选取我院治疗的颈内动脉(ICA)系统的CWI92例,随机分为治疗组(生脉注射液联合低分子右旋糖酐治疗CWI)和对照组(低分子右旋糖酐治疗CWI)各46例,疗程14d。结果:疗程结束后,治疗组其疗效、神经功能缺损(NDS)和ICA系统脑血管收缩期血流速度(Vp)等结果明显优于对照组(P<0.05)。结论:生脉注射液是治疗急性CWI特别是血压偏低患者可供选择的有效药物,未见明显毒副作用,与低分子右旋糖酐联合应用疗效肯定。
Objective： To observe the clinical effects of Shengmai injection in treating watershed cerebral infarction. Methods： 92 cases were randomly divided into 2 groups, the treated group （46 cases） was given Shengrnai injection plus low molecular weight dextran; the control group （46 cases） was given low molecular weight dextran; 14 days for a course.Results： Efficacy, NDS and Vp in the treated group was better （P〈0.05）. Conclusion： Shengmai injection was effective in treating watershed cerebral infarction.
出处
《中医临床研究》
2012年第9期58-58,60,共2页
Clinical Journal Of Chinese Medicine
关键词
生脉注射液
血压
分水岭脑梗死
Shengmai injection
Blood pressure
Watershed cerebral infarction
